Gastrointestinal Disorders
Cannabibs Sp. z o.o. is involved in clinical research focused on irritable bowel syndrome, with attention to the IBS-D symptom profile and its impact on digestive function.
- Abdominal pain
- Cramping
- Bloating
- Distention
The sponsor’s research interest in this area includes symptom control across bowel habit disturbances and related discomfort associated with functional gastrointestinal disease.
Digestive Symptom Management
The clinical trial portfolio reflects an interest in managing the broader symptom burden of irritable bowel syndrome with diarrhea, including nausea and variable bowel movements.
- Nausea
- Diarrhea
- Constipation
- Bowel habit regulation
This area highlights therapeutic attention to day-to-day digestive symptoms that affect patient comfort and intestinal well-being.
Oral Therapeutics
The sponsor is also active in research on oral treatment approaches for chronic digestive conditions, with a focus on patient-facing therapy in a clinical trial setting.
- Oral administration
- Symptom relief
- Patient tolerability
- Safety evaluation
Its research activity in this domain centers on treatment options intended for ongoing use in individuals with persistent functional bowel symptoms.
